A potential change to reduce upcoding in Medicare could worsen health disparities.
Medicare
Posted inPublic Health
The Return of Our Research Newsletter
Meet the man behind our revamped research newsletter.
Posted inCost of Care
Medicare Director Meena Seshamani on CMS’ New Drug Pricing Powers
Medicare director Meena Seshamani discusses her team’s sprint to put historic drug price reforms into action.
Posted inCost of Care
Medicare Releases Details of Major Drug Price Reform
Medicare’s historic plan to slow prescription drug spending is taking shape.
Posted inPublic Health
Three Health Policy Stories to Watch in 2023
In 2023, states will pursue new abortion laws, restart Medicaid eligibility checks and Medicare will begin to flex its new power to negotiate drug prices.
Posted inHealth Equity
Going Beyond Rural Hospital Closures
Jose Fernandez shares new research that examines the causes and ramifications of rural hospital closures.
Posted inPublic Health
Drugmakers and Patient Assistance Programs: Tricks or Treats?
Stacie Dusetzina shares new research that examines the link between drug companies’ charity donations and their business incentives.
Posted inInsurance
Medicare’s Prescription Drug Plan Makeover
An overhaul of Medicare’s prescription drug benefit will lower costs for seniors while changing incentives for insurers and drugmakers.
Posted inInsurance
4 Studies that Explain the Stakes of Medicare Open Enrollment
Leslie Walker shares four research studies to explain the stakes of Medicare open enrollment.
Posted inCost of Care
How Hospitals Respond to Value-based Payment
Yaa Akosa Antwi shares new research on the impact of a pay-for-performance program on hospital quality.